中国癌症杂志2025，Vol.35Issue(10)：941-945,5.DOI:10.19401/j.cnki.1007-3639.2025.10.006
《2025版美国甲状腺学会成人分化型甲状腺癌管理指南》解读:分化型甲状腺癌的外照射放疗进展
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer:progress in external beam radiotherapy(EBRT)for differentiated thyroid cancer
摘要
Abstract
External beam radiotherapy(EBRT)is one of the important treatment methods for head and neck malignant tumors.However,EBRT in differentiated thyroid cancer(DTC)has remained controversial for decades.In 2025,the American Thyroid Association(ATA)updated its clinical practice guidelines for the management of DTC in adults,which is known as the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer(abbreviation ATA guideline).In recent years,various emerging radiotherapy techniques,such as intensity modulated radiotherapy(IMRT)and stereotactic body radiotherapy(SBRT),have been applied in DTC and have achieved positive results.Compared with the 2015 ATA guideline,the revised guidelines adopt a more permissive perspective on EBRT,underscoring the importance of modern radiotherapy techniques and individualized indications.Notably,the recommendations now include the use of EBRT in the management of oligometastatic disease or SBRT.This article compared the2025 ATA guideline with 2015 ATA guideline,then provides a systematic interpretation of the section on EBRT,aiming to provide evidence-based foundation for clinical practice.关键词
分化型甲状腺癌/外照射放疗/寡转移/调强放疗/立体定向放疗/指南解读Key words
Differentiated thyroid cancer/External beam radiotherapy/Oligometastasis/Intensity-modulated radiotherapy/Stereotactic body radiotherapy/Guideline interpretation分类
医药卫生引用本文复制引用
刘晓亮,侯晓荣..《2025版美国甲状腺学会成人分化型甲状腺癌管理指南》解读:分化型甲状腺癌的外照射放疗进展[J].中国癌症杂志,2025,35(10):941-945,5.基金项目
北京协和医院协和人才培育支持计划C类(UBJ04712) （UBJ04712）
十四五国家重点研发计划临床研究及验证评价(2023YFC2411504). Peking Union Medical College Hospital Talent Cultivation Program(Category C)(UBJ04712) （2023YFC2411504）
National Key R&D Program of China,Ministry of Science and Technology of the People's Republic of China(2023YFC2411504). （2023YFC2411504）
